1,407 results on '"Nobili, Valerio"'
Search Results
102. rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis
103. Is there any link between dietary pattern and development of nonalcoholic fatty liver disease in adolescence? An expert review
104. Retinoids Counteract Insulin Resistance And Liver Steatosis: Whatʼs the Potential Mechanism?
105. A new ABCB11 mutation in two Italian children with familial intrahepatic cholestasis
106. Blind and ultrasound-guided percutaneous liver biopsy in children
107. Non-Alcoholic Fatty Liver Disease in Children
108. Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology
109. Pediatric post-transplant metabolic syndrome: New clouds on the horizon
110. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease
111. Role of Fatty Liver Disease in Childhood Obesity
112. Contributors
113. Circulating biomarkers for metabolic disorders as a predictor of cardiovascular disease risk: whatʼs new?
114. Metabolic disorders: all that we know from circulating biomarkers
115. Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease
116. Hedgehog/hyaluronic acid interaction network in nonalcoholic fatty liver disease, fibrosis, and hepatocellular carcinoma
117. I148M PNPLA3 variant and progressive liver disease: A new paradigm in hepatology
118. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach
119. Unraveling the genetics of fatty liver in obese children: Additive effect of P446L GCKR and I148M PNPLA3 polymorphisms
120. Metabolic Syndrome and Alcohol Abuse: A Potential Hepatocarcinogenic Mix in Adolescents
121. PNPLA3 I148M polymorphism and liver damage in obese children
122. Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease development
123. Hepatic stellate cell proliferation: A potential role of protein kinase R
124. Human hepatic stellate cells are liver-resident antigen-presenting cells
125. Use of metformin in pediatric age
126. Alcoholic and Non-alcoholic Fatty Liver in Adolescents: A Worrisome Convergence
127. NONALCOHOLIC FATTY LIVER DISEASE: Targeted therapy in children—what is the right way?
128. Recent advances in biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis: the role of lipid analysis/profiling
129. Metabolic syndrome and nonalcoholic steatohepatitis recurrence after liver transplantation in children
130. Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial
131. Preemptive liver transplantation in a child with familial hypercholesterolemia
132. Activation of the Endotoxin/Toll-Like Receptor 4 Pathway: The Way to Go From Nonalcoholic Steatohepatitis up to Hepatocellular CarcinomaΔ
133. The Wide Spectrum of Hepatic Iron OverloadΔ
134. Fructose at the center of necroinflammation and fibrosis in nonalcoholic steatohepatitis
135. Chapter 16 - Obesity and Nonalcoholic Fatty Liver Disease in Children
136. Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease
137. β-Klotho gene variation is associated with liver damage in children with NAFLD
138. Is juvenile liver biopsy unsafe? Putting an end to a common misapprehension
139. I148M Patatin-Like Phospholipase Domain-Containing 3 Gene Variant and Severity of Pediatric Nonalcoholic Fatty Liver Disease
140. The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis
141. Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease
142. Natural Approach Against Lipotoxic Traffic in Nonalcoholic Fatty Liver Disease
143. Steatosis and fibrosis in paediatric liver transplant: Insidious graftʼs enemies – A call for clinical studies and research
144. Low Levels of 25-Hydroxyvitamin D3 in Children With Biopsy-Proven Nonalcoholic Fatty Liver Disease
145. Plasma N‐terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non‐alcoholic fatty liver disease
146. Acute liver failure and pediatric ALF: strategic help for the pediatric hepatologist
147. Toll-Like Receptor 4: A Starting Point for Proinflammatory Signals in Fatty Liver Disease
148. Hepatitis C Virus and Nonalcoholic Fatty Liver Disease: Similar Risk Factors for Necroinflammation, Fibrosis, and Cirrhosis
149. Childhood NAFLD: a ticking time-bomb?
150. Pediatric Nonalcoholic Fatty Liver Disease in 2009
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.